Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsungda Hsu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Mbio|June 5, 2014
Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosisParas Jain, Tsungda Hsu, Masayoshi Arai, et al.
Clinical and Vaccine Immunology : CVI|September 1, 2006
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatisJae-Sung Yu, James W Peacock, Stacie Vanleeuwen, et al.
Immunology|September 29, 2006
Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gammaAna Paula Junqueira-Kipnis, Randall J Basaraba, Veronica Gruppo, et al.
Vaccine|July 25, 2006
Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosisVasan K Sambandamurthy, Steven C Derrick, Tsungda Hsu, et al.
Immunology|November 2, 2006
Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccineSteven C Derrick, Teresa H Evering, Vasan K Sambandamurthy, et al.
Applied Biosafety : Journal of the American Biological Safety Association|February 16, 2013
Einstein Contained Aerosol Pulmonizer (ECAP): Improved Biosafety for Multi-Drug Resistant (MDR) and Extensively Drug Resistant (XDR) Mycobacterium tuberculosis Aerosol Infection StudiesBing Chen, Torin R Weisbrod, Tsungda Hsu, et al.
Vaccine|June 9, 2009
Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primatesMichelle H Larsen, Karolin Biermann, Bing Chen, et al.
Nature Medicine|September 6, 2011
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosisKari A Sweeney, Dee N Dao, Michael F Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2003
The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissueTsungda Hsu, Suzanne M Hingley-Wilson, Bing Chen, et al.
Vaccine|January 13, 2009
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calvesW Ray Waters, Mitchell V Palmer, Brian J Nonnecke, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Mbio|June 5, 2014
Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosisParas Jain, Tsungda Hsu, Masayoshi Arai, et al.
Clinical and Vaccine Immunology : CVI|September 1, 2006
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatisJae-Sung Yu, James W Peacock, Stacie Vanleeuwen, et al.
Immunology|September 29, 2006
Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gammaAna Paula Junqueira-Kipnis, Randall J Basaraba, Veronica Gruppo, et al.
Vaccine|July 25, 2006
Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosisVasan K Sambandamurthy, Steven C Derrick, Tsungda Hsu, et al.
Immunology|November 2, 2006
Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccineSteven C Derrick, Teresa H Evering, Vasan K Sambandamurthy, et al.
Applied Biosafety : Journal of the American Biological Safety Association|February 16, 2013
Einstein Contained Aerosol Pulmonizer (ECAP): Improved Biosafety for Multi-Drug Resistant (MDR) and Extensively Drug Resistant (XDR) Mycobacterium tuberculosis Aerosol Infection StudiesBing Chen, Torin R Weisbrod, Tsungda Hsu, et al.
Vaccine|June 9, 2009
Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primatesMichelle H Larsen, Karolin Biermann, Bing Chen, et al.
Nature Medicine|September 6, 2011
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosisKari A Sweeney, Dee N Dao, Michael F Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2003
The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissueTsungda Hsu, Suzanne M Hingley-Wilson, Bing Chen, et al.
Vaccine|January 13, 2009
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calvesW Ray Waters, Mitchell V Palmer, Brian J Nonnecke, et al.
Pageof 3